Upstate Active Clinical Trials
Study Title:UTX-TGR-205 - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 alone in Patients with Previously Treated Diffuse Large B-Cell Lymphoma
What is the purpose of the study?This research study will evaluate the safety and efficacy of a study drug called TGR-1202 in combination with another study drug called ublituximab compared to TGR-1202 alone as a possible treatment for Diffuse Large B-cell Lymphoma (DLBCL) that has come back or that has not responded to standard treatment.
Upstate Institutional Review Board (IRB) Number:916778
Patient Age Group:Adults
Principal Investigator:Teresa C Gentile, MD, PhD
What is involved if I participate?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
Who can I contact for more information?
Name: Corey Chase